Express News | NYSE Order Imbalance 177406.0 Shares on Buy Side
Jim Cramer: Beyond Meat Is 'Way Too Risky,' Warby Parker Is 'Alright To Buy'
On CNBC's "Mad Money Lightning Round," Jim Cramer said Warby Parker Inc. (NYSE:WRBY) is "alright to buy."On May 9, Warby Parker reported a year-over-year increase in first-quarter GAAP EPS results and
Warby Parker Announces Participation in the TD Cowen 8th Annual Future of the Consumer Conference
Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the TD Cowen 8th Annual Future of the Consumer
Express News | NYSE Order Imbalance 63011.0 Shares on Sell Side
Earnings Estimates Moving Higher for Warby Parker (WRBY): Time to Buy?
Warby Parker Inc. (WRBY) Is a Great Momentum Stock: Should You Buy?
Express News | NYSE Order Imbalance 90299.0 Shares on Buy Side
Warby Parker Currently Up 10 Consecutive Days, on Pace for Record Winning Streak -- Data Talk
Warby Parker, Inc. Class A ( WRBY ) is currently at $17.10, up $0.20 or 1.18% --Would be highest close since Jan. 12, 2023, when it closed at $17.30 --Currently up 10 consecutive days; up 37.46% ove
Form 144 | Warby Parker(WRBY.US) Insider Proposes to Sell 2.86 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Warby Parker(WRBY.US)$ Insider Warby Parker Impact Foundation intends to sell 178.57K shares of its common stock on May 17, with a total market value of approximately
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Warby Parker (WRBY) and Adaptive Biotechnologies (ADPT)
Assessing Warby Parker: Insights From 5 Financial Analysts
Warby Parker (NYSE:WRBY) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a snapshot of their recent
Express News | UBS Maintains Neutral on Warby Parker, Raises Price Target to $15
Warby Parker Guidance Achievable, Path Still Uncertain, Morgan Stanley Says
Warby Parker (WRBY) could deliver its guidance for Q2 and the full-year but its expectation for selling, general, and administrative expenses, or SG&A, trajectory may be too optimistic, Morgan Stanley
Warby Parker Q1 2024 Earnings: Revenue Surges, Beats Estimates
Warby Parker Is Maintained at Equal-Weight by Morgan Stanley
Warby Parker Is Maintained at Equal-Weight by Morgan Stanley
Warby Parker Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 -6.6% Morgan Stanley $13 → $14 Maintains Equal-Weight 05/09/2024 26.75% Telsey Advisory Group $
Telsey Advisory Remains a Buy on Warby Parker (WRBY)
Express News | Warby Parker Inc : Stifel Raises Target Price to $14 From $12
Research Alert: CFRA Keeps Buy Opinion On Shares Of Warby Parker Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target by $2 to $17
Morgan Stanley Lifts Price Target on Warby Parker to $14 From $13, Keeps Equalweight Rating
Warby Parker (WRBY) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $12 to $19. Price: 14.50, Change: -0.18, Percent Change: -1.23
No Data